Abdalla, A., Byrne, N., Conway, R., Walsh, T., Mannion, G., Hanly, M., . . . Carey, J. J. (2017). Long-term safety and efficacy of biosimilar infliximab among patients with inflammatory arthritis switched from reference product. Open Access Rheumatol.
Čikaški stil citiranjaAbdalla, Abuelmagd, Niamh Byrne, Richard Conway, Thomas Walsh, Geraldine Mannion, Michael Hanly, Miriam O’Sullivan, Ann Maria Curran, i John J. Carey. "Long-term Safety and Efficacy of Biosimilar Infliximab Among Patients With Inflammatory Arthritis Switched From Reference Product." Open Access Rheumatol 2017.
MLA način citiranjaAbdalla, Abuelmagd, et al. "Long-term Safety and Efficacy of Biosimilar Infliximab Among Patients With Inflammatory Arthritis Switched From Reference Product." Open Access Rheumatol 2017.